ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	38/342	191/7206	1.71725267877e-14
ko04380	Osteoclast differentiation	31/342	134/7206	7.02231386954e-14
ko04650	Natural killer cell mediated cytotoxicity	24/342	97/7206	1.12206077965e-11
ko05340	Primary immunodeficiency	13/342	30/7206	2.85036803199e-10
ko04621	NOD-like receptor signaling pathway	28/342	157/7206	8.42625946433e-10
ko05152	Tuberculosis	30/342	187/7206	2.88894719613e-09
ko05140	Leishmaniasis	18/342	75/7206	7.68784845449e-09
ko04064	NF-kappa B signaling pathway	20/342	96/7206	1.53577722614e-08
ko05164	Influenza A	27/342	167/7206	1.56364981783e-08
ko05150	Staphylococcus aureus infection	12/342	36/7206	4.81398465297e-08
ko05145	Toxoplasmosis	22/342	126/7206	8.60537848044e-08
ko04660	T cell receptor signaling pathway	21/342	124/7206	2.9176618788e-07
ko04610	Complement and coagulation cascades	16/342	79/7206	6.54511492265e-07
ko05162	Measles	20/342	120/7206	7.34183134059e-07
ko04620	Toll-like receptor signaling pathway	18/342	100/7206	8.29011547355e-07
ko04630	Jak-STAT signaling pathway	21/342	132/7206	8.58088593624e-07
ko05321	Inflammatory bowel disease (IBD)	13/342	56/7206	1.46128780062e-06
ko05144	Malaria	11/342	45/7206	5.5572084776e-06
ko04672	Intestinal immune network for IgA production	10/342	37/7206	5.61881320657e-06
ko04659	Th17 cell differentiation	17/342	106/7206	8.63775292073e-06
ko04658	Th1 and Th2 cell differentiation	16/342	96/7206	9.60439390819e-06
ko05133	Pertussis	15/342	87/7206	1.19516917914e-05
ko05168	Herpes simplex infection	23/342	182/7206	1.47511772208e-05
ko05323	Rheumatoid arthritis	15/342	89/7206	1.58904527591e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	23/342	191/7206	3.24504185675e-05
ko04640	Hematopoietic cell lineage	12/342	64/7206	3.79059535868e-05
ko04662	B cell receptor signaling pathway	14/342	88/7206	5.92289948047e-05
ko04145	Phagosome	20/342	162/7206	7.48517662839e-05
ko04611	Platelet activation	20/342	163/7206	8.16837971592e-05
ko05330	Allograft rejection	7/342	24/7206	8.75988546133e-05
ko04217	Necroptosis	21/342	178/7206	9.66348453386e-05
ko05034	Alcoholism	1/342	238/7206	0.000246949982415
ko04062	Chemokine signaling pathway	22/342	201/7206	0.000250277059303
ko05320	Autoimmune thyroid disease	7/342	29/7206	0.000321676097426
ko04670	Leukocyte transendothelial migration	17/342	151/7206	0.000764864435065
ko05310	Asthma	5/342	17/7206	0.000901556943797
ko04612	Antigen processing and presentation	11/342	77/7206	0.000936732572785
ko04664	Fc epsilon RI signaling pathway	11/342	77/7206	0.000936732572785
ko05142	Chagas disease (American trypanosomiasis)	15/342	130/7206	0.00119968524244
ko05332	Graft-versus-host disease	5/342	18/7206	0.00120026784661
ko04666	Fc gamma R-mediated phagocytosis	14/342	122/7206	0.00182646381661
ko05132	Salmonella infection	12/342	98/7206	0.00219819128695
ko04310	Wnt signaling pathway	1/342	181/7206	0.00228710119775
ko04728	Dopaminergic synapse	1/342	185/7206	0.00233515796927
ko04623	Cytosolic DNA-sensing pathway	7/342	41/7206	0.00283847726327
ko05224	Breast cancer	1/342	174/7206	0.00334204191359
ko04723	Retrograde endocannabinoid signaling	1/342	175/7206	0.00335827164852
ko05418	Fluid shear stress and atherosclerosis	17/342	173/7206	0.00534792442477
ko05161	Hepatitis B	17/342	173/7206	0.00534792442477
ko04142	Lysosome	15/342	151/7206	0.0057952808574
ko00982	Drug metabolism - cytochrome P450	6/342	37/7206	0.00730193852199
ko04622	RIG-I-like receptor signaling pathway	8/342	62/7206	0.0085285271404
ko04146	Peroxisome	10/342	89/7206	0.00917851268584
ko04514	Cell adhesion molecules (CAMs)	13/342	130/7206	0.0102067183351
ko05020	Prion diseases	6/342	40/7206	0.0107034463277
ko00590	Arachidonic acid metabolism	7/342	52/7206	0.0108220528779
ko00592	alpha-Linolenic acid metabolism	4/342	19/7206	0.0109630683578
ko00120	Primary bile acid biosynthesis	4/342	20/7206	0.013201774991
ko05016	Huntington's disease	3/342	215/7206	0.0136209531931
ko05416	Viral myocarditis	7/342	55/7206	0.0145487649342
ko04114	Oocyte meiosis	1/342	139/7206	0.0148090946384
ko05131	Shigellosis	9/342	82/7206	0.0151783661338
ko04110	Cell cycle	1/342	145/7206	0.0154727329166
ko04940	Type I diabetes mellitus	5/342	32/7206	0.0163694312281
ko04915	Estrogen signaling pathway	1/342	131/7206	0.0214056493062
ko04713	Circadian entrainment	1/342	136/7206	0.0221741909333
ko05134	Legionellosis	8/342	74/7206	0.0233238368656
ko04550	Signaling pathways regulating pluripotency of stem cells	2/342	165/7206	0.0247945570582
ko04144	Endocytosis	25/342	342/7206	0.0267328628208
ko04210	Apoptosis	15/342	180/7206	0.0310946178276
ko04540	Gap junction	1/342	128/7206	0.032132417117
ko00511	Other glycan degradation	4/342	26/7206	0.032609639269
ko04080	Neuroactive ligand-receptor interaction	11/342	423/7206	0.0329449309909
ko04512	ECM-receptor interaction	8/342	79/7206	0.0329818626471
ko05160	Hepatitis C	13/342	153/7206	0.0342690293213
ko05012	Parkinson's disease	2/342	155/7206	0.0346649866399
ko04390	Hippo signaling pathway	3/342	188/7206	0.0357067162072
ko04152	AMPK signaling pathway	2/342	161/7206	0.035968340131
ko00980	Metabolism of xenobiotics by cytochrome P450	5/342	40/7206	0.0393734090146
ko00480	Glutathione metabolism	6/342	55/7206	0.0448523151239
ko00051	Fructose and mannose metabolism	5/342	42/7206	0.0471752259513
ko00966	Glucosinolate biosynthesis	1/342	1/7206	0.0474604496254
ko05206	MicroRNAs in cancer	3/342	177/7206	0.0487620857381
ko05166	HTLV-I infection	21/342	292/7206	0.0492643353095